OKE
77
2
HP
52
2
TGT
31
4
PX
76
-2
NWS
60
2
SRE
57
8
LH
46
-2
FCX
59
2
HES
65
2
NI
75
-2
GME
65
-5
FIS
46
-2
FMC
34
-2
CMG
69
-3
HRL
51
4
BBY
40
-3
SE
61
-4
PNW
67
-3
NWL
56
2
PFE
28
2
OKE
77
2
HP
52
2
TGT
31
4
PX
76
-2
NWS
60
2
SRE
57
8
LH
46
-2
FCX
59
2
HES
65
2
NI
75
-2
GME
65
-5
FIS
46
-2
FMC
34
-2
CMG
69
-3
HRL
51
4
BBY
40
-3
SE
61
-4
PNW
67
-3
NWL
56
2
PFE
28
2
Financhill
Back

Expeditors International of Washington Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
48

EXPD
Expeditors International of Washington

Last Price:
121.46
Seasonality Move:
7.62%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Sell
48
Expeditors International of Washington (EXPD) is a Sell

Is Expeditors International of Washington a Buy, Sell or Hold?

  • The current Expeditors International of Washington [EXPD] share price is $121.64. The Score for EXPD is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • EXPD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EXPD Stock Price Chart

What is Expeditors International of Washington's stock price today?

  • The Expeditors International of Washington share price today is $121.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPD is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

EXPD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 54.09 Buy
Chaikin Money Flow: 168836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.09 - 121.25) Buy
Bollinger Bands (100): (119.2 - 124.44) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

EXPD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 120.74 Buy
20-day SMA: 120.3 Buy
50-day SMA: 121.82 Sell
200-day SMA: 120.74 Buy
8-day EMA: 121.08 Buy
20-day EMA: 120.67 Buy
50-day EMA: 121.1 Buy
200-day EMA: 120.91 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

Expeditors International of Washington Earnings Growth & EXPD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.04 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Expeditors International of Washington Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):